Early increase in eosinophil count may predict long‐term hypereosinophilia during dupilumab treatment: a 2‐year observational study

Andrea Rampi, Umberto Tanzini, Alessandro Vinciguerra, Giulia Danè, Luca Moroni, Mona‐Rita Yacoub, Matteo Trimarchi

International Forum of Allergy & Rhinology · 2023 · 12 citations · 8 references

DOIFull text

Open access

Concepts

Abstract

KEY POINTS: In a limited subset of patients, dupilumab-induced hypereosinophilia is persistent. Two-month follow-up eosinophil count may predict long-lasting hypereosinophilia.

References

8